Pelizzon David R, DIR, reported an open-market or private sale at ORTHOPEDIATRICS CORP involving 16300.000000 shares for an estimated $403262.00. Reported holdings after the transaction were 6881464.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
No officer title
This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82,
inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission,
upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these…
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provi…
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provi…
Includes restricted stock awards totaling 17,959 shares.
0 other filings
0 recent txs